Sociedades Científicas

Sociedades y Asociaciones Científicas

  • 1982-: Osaka University Psychiatric Association.
  • 1983: International Association of Social Psychiatry.
  • 1983-84: Japanese Branch of the International Association for Social Psychiatry.
  • 1983-: The Japanese Society of Endocrinology.
  • 1983-: The Japanese Neurochemical Society.
  • 1985-: The Japanese Neuroscience Society.
  • 1985-: The Japanese Society of Pharmacology.
  • 1985-: European Neuroendocrine Association.
  • 1985-: International Society of Psychoneuroendocrinology.
  • 1985-: The Japanese Society of Geriatrics.
  • 1985-: European Histamine Research Society.
  • 1987-: Sociedad Española de Endocrinología.
  • 1989-: Asociación Gallega de Psiquiatría.
  • 1989-: European Neuroscience Association.
  • 1989-: European College of Neuropsychopharmacology.
  • 1989-: Sociedad Española de Neurociencias.
  • 1990-: International Psychogeriatric Association.
  • 1992-: New York Academy of Sciences.
  • 1992-: American Association for the Advancement of Science.
  • 1993-: Asociación Española de Neurogerontología y Neurogeriatría.
  • 1995-: American Association for Clinical Chemistry.
  • 1997: Sociedad de Neurociencias de Cuba.
    Sección de Demencias y Enfermedad de Alzheimer.
  • 1997-: American Society of Hispanic Psychiatry.
  • 2001-: The Japanese Psychogeriatric Society.
  • 2001-: The American Geriatrics Society.
  • 2001-: Drug Information Association.
  • 2002-: International Society of Lyophilization-Freeze Drying, Inc.
  • 2002-: Human Genome Variation Society.
  • 2004-: The American Geriatrics Society. AGS ID: 053617.
  • 2005-: Sociedad Española de Medicina Genómica.
  • 2005-: Sociedad Española de Nutracéutica Médica.
  • 2007-: World Association for Cancer Research.
  • 2008-: World Association of Genomic Medicine.

    • Comités de Expertos

  • International Alzheimer’s disease Advisory Board.
    Tacrine (Parke-Davis)(1993-).
  • Chairman, First International Course on Neurogerontology and Psychogeriatrics.
    EUROESPES Foundation, La Coruña (1993-).
  • International Scientific Advisory Committee.
    Fourth International Conference on Alzheimer’s Disease and Related Disorders, Minneapolis (1993-1994).
  • International Organizing Committee.
    International Springfield Committee on Advances in Alzheimer therapy, Springfield, IL (1993-1994).
  • European Scientific Committee of Alzheimer’s disease.
    S-12024, Servier, Paris (1992-).
  • Faculty Member, The Karolinska Institute Postgraduate Education Series, Stockholm.
    (1994-).
  • International Scientific Advisory Committee for the Evaluation Program for Reminyl (Sabeluzole) in Alzheimer’s Disease.
    Sabeluzole, Janssen, New York (1995-).
  • International Scientific Advisory Committee for Assessing Therapeutic Response in Alzheimer’s Disease. Quality of Life.
    Xanomeline, Eli Lilly, Paris (1995-).
  • International Working Group on Harmonization of Dementia Drug Guidelines.
    USA (1995-).
  • International Organizing Committee. Fourth International Nice/Springfield Symposium on Alzheimer Therapy.
    Nice/Springfield (1995-1996).
  • International Scientific Advisory Committee for the Fifth International Conference on Alzheimer’s Disease and Related Disorders.
    Osaka (1995-1996).
  • European Coordinator of S-20298/Phase IIb-Alzheimer, IRIS, Paris (3.1.1996).
  • European Concerted Action on Pick’s Disease (ECAPD) Consortium (1997-1998).
  • Novartis Gerontological Foundation (1998).
  • Comité Consellería Industria/Xunta de Galicia-IGAPE-AFEG-COTEC de Innovación Tecnológica (1998).
  • International Organizing Committee. Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy, Ginebra (1997).
  • International Working Group on Prevention of Alzheimer’s Disease.
    Ronald & Nancy Reagan Institute of the Alzheimer’s Association Ginebra (1998).
  • International Committee. 6th International Conference on Alzheimer’s Disease and Related Disorders, Amsterdam (1998).
  • International Organizing Committee. Sixth International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy. Stockholm (1999-2006).
  • International Advisory Board. Celocoxib. Searle/Monsanto (1998-1999).
  • International Advisory Board. FK960. Fujisawa (1999-2001).
  • Comité de Honor. Fundación Humanismo y Ciencia. Madrid (2000).
  • Alzheimer’s Disease-Advisory Meeting. GlaxoSmithKline (2002).
  • Sociedad Estatal para Exposiciones Internacionales (SEEI) (2003-2005).
  • Internationale Stichting Alzheimer Onderzoek (ISAO) (2003).
  • The Council of Heart and Life Sciences, The Netherlands Government (2004).
  • Medical Research Council, United Kingdom (2004).
  • Genome Canada (2005).
  • Karolinska Institutet (2005).
  • Research into Aging. Help the Aged, United Kingdom (2005).
  • Sociedad Iberoamericana de la Información Científica (2005).
  • Michael Smith Foundation for Health Research, Canadá (2005).
  • Expo 2005 Aichi. Pabellón de España. Comisión España Aichi 2005 (Japón).
  • International Psychogeriatric Association (IPA).
    IPA 2007 Osaka Silver Congress (2007).
  • Presidente, Comité Científico, World Association for Cancer Research (2007).
  • Takeda Pharmaceutical Industry. New Technologies/Methodologies for the Development of Disease-Modifying Compounds for Alzheimer’s Disease and Parkinson’s Disease, Miami, USA (2008).
  • Novartis Consultant, Kyoto (2013).